Public company info - Ascletis Pharma Inc. , 01672.HK
Input the stock code or the company name     Search  
 
 Profile   Information   Data   Financial Ratios   Profit Loss   Cash Flow   Balance   Earnings   Dividend 

Ascletis Pharma Inc., 01672.HK - Cash Flow 2022-12 2021-12 2020-12 2019-12 2018-12 2017-12 2016-12
Net Cash Flow from Operating Activities -168,034 -171,340 -142,532 -138,099 -115,813 -190,328 -12,498
Net Cash Flow from Return on Investments & Servicing of Finance 25,424 24,285 57,486 63,758 -35,401 6,748 -64,377
　Interest Received 25,581 24,410 57,621 63,758 19,223 0 0
　Interest Paid -157 -125 -135 0 0 -317 0
　Dividend Received 0 0 0 0 3,191 7,065 99
　Dividend Paid 0 0 0 0 -57,815 0 -64,476
　Others 0 0 0 0 0 0 0
Taxes (Paid) / Refunded 0 0 0 0 0 -7,728 0
Net Cash Flow from Investing Activities -1,297,387 -274,492 132,297 602,269 -820,662 -651,607 -37,732
　Additions to Fixed Assets -7,070 -4,968 -4,922 -18,885 -15,816 -15,298 -44,606
　Disposal of Fixed Assets 0 0 6 665 0 10 0
　Increase in Investments -482,000 -337,400 -95,070 -67,400 -229,000 -843,500 -5,610
　Decrease in Investments 479,322 334,684 75,708 0 372,000 706,110 14,000
　Net Cash Flow with Related Parties 0 0 0 0 0 549,679 395,199
　Others -1,287,639 -266,808 156,575 687,889 -947,846 -1,048,608 -396,715
Net Cash Flow before Financing Activities -1,439,997 -421,547 47,251 527,928 -971,876 -842,915 -114,607
Net Cash Flow from Financing Activities -1,262 -30,973 -21,535 -48,217 2,617,957 549,679 152,635
　New Loans 0 0 0 0 0 0 0
　Loans Repayment -2,223 -2,284 -1,934 -1,948 0 0 0
　Fixed Income/Debt Instruments 0 0 0 0 0 0 0
　Repayment of Fixed Income/Debt Instruments 0 0 0 0 -249,954 0 0
　Equity Financing 961 0 0 0 2,970,782 0 0
　Net Cash Flow with Related Parties 0 0 0 0 0 549,679 395,199
　Others 0 -28,689 -19,601 -46,269 -102,871 0 -242,564
Increase(Decrease) in Cash & Cash Equivalents -1,441,259 -452,520 25,716 479,711 1,646,081 -293,236 38,028
Cash & Cash Equivalents at Beginning of Year 1,727,411 2,210,504 2,295,044 1,781,892 123,697 418,973 372,398
Net Cash Flow due to Change in Exchange Rate/Others 117,616 -30,573 -110,256 33,441 12,114 -2,040 8,547
Cash & Cash Equivalents at End of Year 403,768 1,727,411 2,210,504 2,295,044 1,781,892 123,697 418,973
Currency Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi Renminbi
Unit
Auditor's Opinion 1 1 1 1 1 0 0

Notes:1–Unqualified; 2–Unqualified ( not qualified in respect of fundamental uncertainly because of proper disclosure); 3–Qualified

 
88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2025
Suntek Computer Systems Limited.
All rights reserved